Literature DB >> 8216820

Morphologic analysis of three-dimensional tumors developed in fibrin matrix and agar culture system.

H Kumazawa1, M Hess, P Koldovsky.   

Abstract

The three-dimensional growth of cultured tumor cell lines (HT29, a colon adenocarcinoma cell line; M21, a melanoma cell line; KB, a nasopharyngeal carcinoma cell line) has been investigated in an agar culture system with a fibrin matrix in vitro. The tumor cells developed to tumors 3 x 3 mm in diameter after 10 days in culture in vitro. This size was large enough to allow histologic examination. The tumor cells located in the surface area of the three-dimensional tumor seemed to grow well. However, the tumor cells in the center degenerated or did not proliferate, indicating a lack of nutrition and/or anoxia in the center. The histologic comparison between the xenografted tumors on nude mice and the three-dimensional tumors in vitro suggests that the structures of the three-dimensional tumors were comparable, especially in the surface area, to the xenografted tumors. Furthermore, the antitumor effect of mitomycin C on the three-dimensional tumors was found to be dose-dependent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216820     DOI: 10.1159/000163757

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  3 in total

1.  Growth of adenocarcinoma on routine microbiological media inoculated with fluid from a pleural effusion in an 82-year-old female.

Authors:  Kenneth L Muldrew; Stephen C Edberg
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

2.  From passive diffusion to active cellular migration in mathematical models of tumour invasion.

Authors:  P Tracqui
Journal:  Acta Biotheor       Date:  1995-12       Impact factor: 1.774

3.  Influence of LAK cells on expression of HLA-DR antigen on laryngeal carcinoma cell line in new culture systems.

Authors:  H Kumazawa; T Kumazawa; T Tachikawa; S Sai; T Yamashita; K Kawamoto
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.